
Lawrence Lustig
Chair & Co-Program Director · New York Presbyterian Hospital
Credentials: · · · · ·
History
PresentChair & · New York Presbyterian Hospital
PresentOtolaryngology-Head & Neck Surgery Department · New York Presbyterian Hospital
PresentDepartment of Otolaryngology-Head & Neck Surgery · New York Presbyterian Hospital
- 1998–2000
- 1992–1997
- 1984–1988
Research
Review · Nature Reviews Disease Primers · 2017 · 391 citations
Sensorineural deafness and seizures in mice lacking vesicular glutamate transporter 3
Neuron · 2008 · 316 citations
Restoration of hearing in the VGLUT3 knockout mouse using virally mediated gene therapy
Neuron · 2012 · Last of 8 authors · 306 citations

39 papers
- JK
38 papers
- DK
37 papers

37 papers

37 papers

36 papers
- BW
34 papers

26 papers
Grants
- 2011–2013
Virally Mediated Gene Therapy for Genetic Hearing Loss
National Institute on Deafness and Other Communication Disorders · R21
Contact PI · $429.3K · University of California, San Francisco
- 2000–2006
Characterization of the Human Hair Cell Receptor Alpha-9
National Institute on Deafness and Other Communication Disorders · K08
Contact PI · $866.4K · University of California, San Francisco
Clinical trials
- 2017–2021
In-Office Tympanostomy Tube Placement in Children (OTTER)
Principal investigator · Completed · Phase 3
Tusker Medical
- 2008
Is Topiramate Effective in Treating Dizziness in Patient's With Migraine-Associated Dizziness
Principal investigator · Withdrawn
University of California, San Francisco
- 2007–2010
Development of Auditory Skills in Young Deaf Children With Bilateral Cochlear Implants
Principal investigator · Withdrawn
University of California, San Francisco
- 2023–2027
Site PI · Recruiting
Smith & Nephew, Inc.



